Ann: FY23 Annual Report, page-5

Thats the best reading Chairman and MD report we have had. For any holders needing a sniff of optimism read those twice and look to the next 6 months. Very positive language regarding Fuji, specifically mentions big pharma and 3 new customers on line by the end of year plus acknowledgement of the "Achilles heal" referring to the share price.

Some further funding required but with a solid R and D refund coming and increasing sales any raise will be at a much better price.

Great reading.